[1] Sonzogni L, Ronzoni L, Graziadei G, et al.Ferroportin expression and regulation in non-transfusion dependent thalassemia[J]. Blood Cells Mol Dis, 2016,58:26-28.
[2] 郑法雷, 袁群生. 慢性肾脏病贫血患者补铁治疗的三个要点[J]. 肾脏病与透析肾移植杂志,2008,17(4):347-348.
[3] Valenti L, Messa P, Pelusi S, et al.Hepcidin levels in chronic hemodialysis patients: a critical evaluation[J]. Clin Chem Lab Med,2014,52(5):613-619.
[4] Speer MY, Yang HY, Brabb T, et al.Smooth muscle cells give rise to osteochondrogenic precursors and chondrocytes in calcifying arteries[J]. Circ Res, 2009,104(6):733-741.
[5] Back M, Gasser TC, Michel JB, et al.Biomechanical factors in the biology of aortic wall and aortic valve diseases[J]. Cardiovasc Res,2013,99(2):232-241.
[6] Balogh E, Tolnai E, Nagy B Jr, et al.Iron overload inhibits osteogenic commitment and differentiation of mesenchymal stem cells via the induction of ferritin[J]. Biochim Biophys Acta,2016,1862(9):1640-1649.
[7] Zarjou A, Jeney V, Arosio P, et al.Ferritin ferroxidase activity: a potent inhibitor of osteogenesis[J]. J Bone Miner Res,2010,25(1):164-172.
[8] Becs G, Zarjou A, Agarwal A, et al.Pharmacological induction of ferritin prevents osteoblastic transformation of smooth muscle cells[J]. J Cell Mol Med, 2016,20(2):217-230.
[9] Zarjou A, Jeney V, Arosio P, et al.Ferritin prevents calcification and osteoblastic differentiation of vascular smooth muscle cells[J]. J Am Soc Nephrol,2009,20(6):1254-1263.
[10] Yang Q, Jian J, Abramson SB, et al.Inhibitory effects of iron on bone morphogenetic protein 2-induced osteoblastogenesis[J]. J Bone Miner Res, 2011,26(6):1188-1196.
[11] Guo JP, Pan JX, Xiong L, et al.Iron chelation inhibits osteoclastic differentiationin vitroand in Tg2576 mouse model of alzheimer's disease[J]. PLoS One,2015,10(11):e0139395.
[12] Xie W, Lorenz S, Dolder S, et al.Extracellular iron is a modulator of the differentiation of osteoclast lineage cells[J]. Calcif Tissue Int,2016,98(3):275-283.
[13] Zhao GY, Di DH, Wang B, et al.Effects of mouse hepcidin 1 treatment on osteoclast differentiation and intracellular iron concentration[J]. Inflammation, 2015,38(2):718-727.
[14] Lu H, Lian L, Shi D, et al.Hepcidin promotes osteogenic differentiation through the bone morphogenetic protein 2/small mothers against decapentaplegic and mitogen-activated protein kinase/P38 signaling pathways in mesen-chymal stem cells[J]. Mol Med Rep, 2015,11(1):143-150.
[15] Li GF, Xu YJ, He YF, et al.Effect of hepcidin on intracellular calcium in human osteoblasts[J]. Mol Cell Biochem,2012,366(1-2):169-174.
[16] Jiang Y, Yan Y, Wang X, et al.Hepcidin inhibition on the effect of osteogenesis in zebrafish[J]. Biochem Biophys Res Commun,2016,476(1):1-6.
[17] Seto T, Hamada C, Tomino Y.Suppressive effects of iron overloading on vascular calcification in uremic rats[J]. J Nephrol,2014,27(2):135-142.
[18] Phan O, Maillard M, Funk F, et al.Effect of PA21, a new iron-based phosphate binder on fibroblast growth factor 23 (FGF23) and vascular calcifications in uremic rats[J]. J Hypertens,2015,33(Suppl 1):e16-e17.
[19] 李萍, 陈孜瑾, 蒋钻红, 等. 维持性血液透析患者血浆铁调素水平及其影响因素分析[J]. 中国血液净化,2017,16(1):30-34.
[20] 黄振华, 冯振伟, 叶智明, 等. 血清铁调素25水平对腹膜透析患者心血管事件的影响及相关因素[J]. 中华肾脏病杂志,2013,29(12):932-933. |
